References
- ChavanSBrayFLortet-TeulentJGoodmanMJemalAInternational variations in bladder cancer incidence and mortalityEur Urol2014661597324451595
- MahdavifarNGhonchehMPakzadRMomenimovahedZSalehiniyaHEpidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the worldAsian Pac J Cancer Prev201617138138626838243
- EiflerJBBarocasDAResnickMJPredictors of outcome in bladder cancerJ Natl Compr Canc Netw201412111549155425361801
- SalamaRHSelemTHEl-GammalMElhagagyAEBakarSMUrinary tumor markers could predict survival in bladder carcinomaIndian J Clin Biochem201328326527124426222
- GargMPrognostic and therapeutic applications of the molecular events in clinical management of urothelial carcinoma of bladderJ ExpTher Oncol2014104301316
- HarshmanLCPrestonMABellmuntJBeardCDiagnosis of bladder carcinoma: a clinician’s perspectiveSurg Pathol Clin20158467768526612221
- SchwingshacklLHoffmannGAdherence to mediterranean diet and risk of cancer: an updated systematic review and meta-analysis of observational studiesCancer Med20154121933194726471010
- CumberbatchMGCoxATeareDCattoJWContemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysisJAMA Oncol2015191282129026448641
- DobruchJDaneshmandSFischMGender and bladder cancer: a collaborative review of etiology, biology, and outcomesEur Urol201669230031026346676
- KimJYKimJHParkTJPositive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case studyBMC Pulm Med2010103420513247
- GjerstorffMFAndersenMHDitzelHJOncogenic cancer/testis antigens: prime candidates for immunotherapyOncotarget2015618157721578726158218
- ZhangHLuoMJinZExpression and clinicopathological significance of FSIP1 in breast cancerOncotarget2015612106581066625826084
- ChapmanKBPrendesMJKiddJLSternbergHWestMDWagnerJElevated expression of cancer/testis antigen FSIP1 in ER-positive breast tumorsBiomark Med20137460161123905897
- MaoYXuRLiuXShiWHanYElevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patientsOncotarget201787121861219328086239
- KaragasMRAndrewASNelsonHHSLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancerHum Genet2012131345346121947419
- KluthLABlackPCBochnerBHPrognostic and prediction tools in bladder cancer: a comprehensive review of the literatureEur Urol201568223825325709027
- KhanRIbrahimHTulpuleSIrokaNBladder cancer in a young patient: undiscovered risk factorsOncol Lett20161153202320427123090
- TelliOSariciHOzgurBCUrothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomesKaohsiung J Med Sci201430946647025224770
- BordenLSJrClarkPEHallMCBladder cancerCurr Opin Oncol200315322723312778017
- MathieuRLuccaIRouprêtMBrigantiAShariatSFThe prognostic role of lymphovascular invasion in urothelial carcinoma of the bladderNat Rev Urol201613847147927431340
- BrownPRMikiKHarperDBEddyEMA-kinase anchoring protein 4 binding proteins in the fibrous sheath of the sperm flagellumBiol Reprod20036862241224812606363
- LabhartPKarmakarSSalicruEMIdentification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivatorProc Natl Acad Sci U S A200510251339134415677324
- ShouJMassarwehSOsborneCKMechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJ Natl Cancer Inst2004961292693515199112